HAMILTON LANE ADVISORS LLC - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 18 filers reported holding INHIBIKASE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HAMILTON LANE ADVISORS LLC ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$50
-7.4%
13,802
-83.3%
0.02%
+27.8%
Q1 2023$54
-100.0%
82,817
-50.0%
0.02%
-67.3%
Q3 2022$151,000
+22.8%
165,6350.0%0.06%
+14.6%
Q2 2022$123,000
-49.8%
165,6350.0%0.05%
-12.7%
Q1 2022$245,000165,6350.06%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 937,500$696,0000.97%
HAMILTON LANE ADVISORS LLC 165,635$123,0000.05%
Redmond Asset Management, LLC 122,682$91,0000.03%
Retirement Planning Co of New England, Inc. 64,606$47,0000.03%
Antara Capital LP 403,000$299,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$70,0000.01%
Koshinski Asset Management, Inc. 65,377$49,0000.01%
K.J. Harrison & Partners Inc 18,300$14,0000.00%
Warberg Asset Management LLC 14,493$11,0000.00%
Shay Capital LLC 10,708$8,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders